选择性5-羟色胺再摄取抑制剂与5-羟色胺-去甲肾上腺素再摄取抑制剂与心脏手术患者出血或输血无关
本研究基于2004至2014年在本机构接受体外循环心脏手术的成人患者,通过倾向性评分1:1匹配比较服用SSRI/SNRI者与未服用者的围术期结局。共纳入1417对匹配患者,结果显示SSRI/SNRI组与对照组在术后胸管引流量、因出血再手术率及围术期输血率上均无显著差异;但SSRI/SNRI组 prolonged mechanical ventilation 发生率更高、ICU及住院时间更长,30天死亡率等其余结局相似。结论认为SSRI/SNRI不增加心脏手术出血或输血风险,围术期中断此类药物以减少出血风险缺乏依据。
要点
- 服用SSRI/SNRI的心脏手术患者术后胸管引流量、因出血再手术率及围术期输血率与匹配对照组无显著差异。
- 围术期不应为减少出血或输血风险而中断SSRI/SNRI,以免导致患者精神状况不稳定。
核心结论
- SSRI/SNRI使用与心脏手术患者出血或输血风险增加无关。
- SSRI/SNRI组 prolonged mechanical ventilation 及ICU/住院时间增加,但不确定是否由药物本身或潜在精神疾病所致。
- 围术期中断SSRI/SNRI以减少围术期出血和输血风险缺乏依据,且可能 destabilize 患者精神状况。
研究设计与样本
- 通过倾向性评分1:1匹配服用SSRI/SNRI的患者与未服用者,最终保留1417对匹配患者进行分析。
临床怎么用
- 心脏手术患者围术期可继续使用SSRI/SNRI,无需为降低出血或输血风险而中断。
- 对于服用SSRI/SNRI的心脏手术患者,应关注 prolonged mechanical ventilation 及ICU/住院时间延长的风险。
局限性
- 研究为单中心回顾性设计,结果外推需谨慎。
- prolonged mechanical ventilation 及住院时间延长的原因无法区分是药物效应还是潜在精神疾病所致。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Selective serotonin reuptake inhibitor (SSRI) and serotonin-norepinephrine reuptake inhibitor (SNRI) use is known to alter platelet activation and aggregation leading to impairment in hemostasis. Previous studies are ambiguous with regard to bleeding, transfusion, and perioperative complications in patients undergoing cardiac surgery. The purpose of this study was to evaluate the risk of perioperative bleeding, transfusion, morbidity, and mortality in cardiac surgical patients taking SSRI/SNRIs compared with propensity-matched controls. METHODS: Adult patients undergoing cardiac surgery with cardiopulmonary bypass at our institution between January 1, 2004, and December 31, 2014, were eligible for study inclusion. Patients taking SSRI/SNRI medications at the time of surgery were identified and compared against all other patients not taking SSRI/SNRI medications to produce well-matched groups via propensity score analysis. Patients taking SSRI/SNRI medications were matched in a 1:1 ratio to control patients not taking these medications based on an internally estimated propensity score. Primary outcomes included perioperative blood transfusion, chest tube output, and reoperation for bleeding. Secondary outcomes included postoperative complications (renal failure, stroke or transient ischemic accident, prolonged mechanical ventilation, and perioperative myocardial infarction), intensive care unit (ICU) and hospital length of stay (LOS), and 30-day mortality. RESULTS: A total of 1417 pairs of SSRI/SNRI patients and matched controls were retained for analysis. Between SSRI/SNRI patients and matched controls, there was no significant difference in postoperative chest tube output (median, 750.0 vs 750.0 mL; P = .860) or reoperation for bleeding (2.8% vs 2.5%; P = .892). Perioperative transfusion rates across all time points and blood product type were not significantly different between groups, with the overall perioperative transfusion rate for SSRI/SNRI patients 66.5% vs 64.9% for matched controls (P = .697). Patients in the SSRI/SNRI group had a higher rate of prolonged mechanical ventilation (13.1% vs 8.6%; P = .002), longer ICU LOS (median, 25.5 vs 23.8 hours; P < .001), and longer hospital LOS (median, 6.0 vs 5.0 days; P < .001). Remaining mortality and outcome data were similar between groups. CONCLUSIONS: SSRI/SNRI use was not associated with an increased risk of bleeding or transfusion in patients undergoing cardiac surgery. While there was prolonged mechanical ventilation and increased ICU/hospital LOS in the SSRI/SNRI group, it is unclear that this finding is the result of such medications or rather associated with the underlying psychiatric condition for which they are prescribed. The results of this study suggest that perioperative interruption of SSRI/SNRIs to reduce the risk of perioperative bleeding and transfusion is unwarranted and may risk destabilization of patients' psychiatric condition.
引用
- Smith MM, Smith BB, Lahr BD, et al. Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors Are Not Associated With Bleeding or Transfusion in Cardiac Surgical Patients. Anesth Analg. 2018. PMID: 29210786. doi:10.1213/ANE.0000000000002668
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。